Philippe R. Bovy

1.3k total citations
40 papers, 1.1k citations indexed

About

Philippe R. Bovy is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Philippe R. Bovy has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 19 papers in Molecular Biology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Philippe R. Bovy's work include Chemical Synthesis and Analysis (11 papers), Catalytic Cross-Coupling Reactions (6 papers) and Heart Failure Treatment and Management (4 papers). Philippe R. Bovy is often cited by papers focused on Chemical Synthesis and Analysis (11 papers), Catalytic Cross-Coupling Reactions (6 papers) and Heart Failure Treatment and Management (4 papers). Philippe R. Bovy collaborates with scholars based in United States, France and Belgium. Philippe R. Bovy's co-authors include Sylvain Rault, Valérie Collot, Gillian M. Olins, Jean‐Charles Lancelot, Alexandre Bouillon, Joseph G. Rico, Ronald Breslow, Patrick Dallemagne, Thomas E. Rogers and Angelo J. Trapani and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Hypertension.

In The Last Decade

Philippe R. Bovy

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe R. Bovy United States	19	561	421	235	88	64	40	1.1k
S. KLUTCHKO United States	15	624 1.1×	399 0.9×	122 0.5×	84 1.0×	37 0.6×	33	1.0k
Michael Czarniecki United States	21	642 1.1×	646 1.5×	98 0.4×	71 0.8×	81 1.3×	46	1.3k
Herman H. Stein United States	20	548 1.0×	652 1.5×	264 1.1×	105 1.2×	82 1.3×	59	1.3k
Joseph B. Santella United States	11	567 1.0×	312 0.7×	92 0.4×	88 1.0×	52 0.8×	19	901
Wasyl Halczenko United States	13	352 0.6×	448 1.1×	103 0.4×	72 0.8×	40 0.6×	49	1.0k
Allan Hallett United Kingdom	12	227 0.4×	405 1.0×	72 0.3×	67 0.8×	64 1.0×	17	621
Raj N. Misra United States	19	525 0.9×	287 0.7×	45 0.2×	130 1.5×	24 0.4×	37	924
Bernd Riedl Germany	20	482 0.9×	684 1.6×	67 0.3×	148 1.7×	134 2.1×	42	1.2k
Cleo J. C. Connolly United States	10	506 0.9×	352 0.8×	111 0.5×	48 0.5×	43 0.7×	13	802
Brian A. Chauder United States	16	332 0.6×	596 1.4×	76 0.3×	73 0.8×	145 2.3×	23	928

Countries citing papers authored by Philippe R. Bovy

Since Specialization

Citations

This map shows the geographic impact of Philippe R. Bovy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe R. Bovy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe R. Bovy more than expected).

Fields of papers citing papers by Philippe R. Bovy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe R. Bovy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe R. Bovy. The network helps show where Philippe R. Bovy may publish in the future.

Co-authorship network of co-authors of Philippe R. Bovy

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe R. Bovy. A scholar is included among the top collaborators of Philippe R. Bovy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe R. Bovy. Philippe R. Bovy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guillon, Jean, Patrick Dallemagne, Jean‐Michel Léger, et al.. (2002). Synthesis of a Novel Class of Non-Peptide NK-2 Receptor Ligand, Derived from 1-Phenyl-3-pyrrol-1-ylindan-2-carboxamides. Bioorganic & Medicinal Chemistry. 10(4). 1043–1050. 22 indexed citations

Bouillon, Alexandre, Jean‐Charles Lancelot, Valérie Collot, Philippe R. Bovy, & Sylvain Rault. (2002). Synthesis of novel halopyridinylboronic acids and esters. Part 3: 2, or 3-Halopyridin-4-yl-boronic acids and esters. Tetrahedron. 58(22). 4369–4373. 53 indexed citations

Bovy, Philippe R., et al.. (2000). Enantioselective Sharpless Dihydroxylation of Vinylic Aromatic Heterocycles. Synthesis. 2000(1). 127–134. 2 indexed citations

Fabis, Frédéric, et al.. (1998). Synthesis of new pyrrolo[2,1-b]quinazolinones by original rearrangement of pyrrolo[2,1-c][1,4]benzodiazepines. Tetrahedron Letters. 39(8). 819–820. 7 indexed citations

Bovy, Philippe R., et al.. (1997). Asymmetric synthesis of both enantiomers of 2-(dimethylamino)-1-[3-methoxy-2-(1-methylethoxy)phenyl]ethanol. European Journal of Medicinal Chemistry. 32(11). 881–888. 1 indexed citations

Zablocki, Jeffery A., Foe S. Tjoeng, Philippe R. Bovy, et al.. (1995). A novel series of orally active antiplatelet agents. Bioorganic & Medicinal Chemistry. 3(5). 539–551. 30 indexed citations

Rico, Joseph G., Robert B. Garland, Thomas E. Rogers, et al.. (1995). Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 38(13). 2378–2394. 86 indexed citations

Luhmer, Michel, Kristin Bartik, Annick Dejaegere, Philippe R. Bovy, & Jacques Reisse. (1994). The importance of quadrupolar interactions in molecular recognition processes involving a phenyl group. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 131(5). 603–606. 13 indexed citations

Bovy, Philippe R., F. S. TJOENG, Thomas E. Rogers, et al.. (1994). Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents. Bioorganic & Medicinal Chemistry. 2(9). 881–895. 10 indexed citations

10.

Rogers, Thomas E., et al.. (1994). ChemInform Abstract: A Highly Stereoselective Michael Addition to an α,β‐ Unsaturated Ester as the Crucial Step in the Synthesis of a Novel . beta.‐Amino Acid‐Containing Fibrinogen Receptor Antagonist.. ChemInform. 25(20). 1 indexed citations

11.

Bovy, Philippe R., David B. Reitz, Joseph T. Collins, et al.. (1993). Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 36(1). 101–110. 34 indexed citations

12.

Rico, Joseph G., et al.. (1993). A highly stereoselective Michael addition to an .alpha.,.beta.-unsaturated ester as the crucial step in the synthesis of a novel .beta.-amino acid-containing fibrinogen receptor antagonist. The Journal of Organic Chemistry. 58(27). 7948–7951. 47 indexed citations

13.

Bovy, Philippe R., Daniel P. Getman, John Matsoukas, & Graham J. Moore. (1991). Influence of polyfluorination of the phenylalanine ring of angiotensin II on conformation and biological activity. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1079(1). 23–28. 13 indexed citations

14.

Bovy, Philippe R., Joseph T. Collins, Gillian M. Olins, Ellen G. McMahon, & William Hutton. (1991). Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties. Journal of Medicinal Chemistry. 34(8). 2410–2414. 23 indexed citations

15.

Bovy, Philippe R., Gillian M. Olins, Ellen G. McMahon, et al.. (1990). Structure-activity relationships for the carboxy-terminus-truncated analogs of angiotensin II, a new class of angiotensin II antagonists. Journal of Medicinal Chemistry. 33(5). 1477–1482. 11 indexed citations

16.

Koepke, J P, Pramod P. Mehta, Gillian M. Olins, et al.. (1990). Atriopeptin Regulation and Renal Function in Conscious Spontaneously Hypertensive Rats. American Journal of Hypertension. 3(8_Pt_1). 622–627. 6 indexed citations

17.

Bovy, Philippe R.. (1990). Structure activity in the atrial natriuretic peptide (ANP) family. Medicinal Research Reviews. 10(1). 115–142. 50 indexed citations

18.

Bovy, Philippe R., et al.. (1989). A carboxy-terminus truncated analog of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists. Journal of Medicinal Chemistry. 32(3). 520–522. 14 indexed citations

19.

Olins, Gillian M., Philip A. Krieter, Angelo J. Trapani, Kerry L. Spear, & Philippe R. Bovy. (1989). Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo. Molecular and Cellular Endocrinology. 61(2). 201–208. 62 indexed citations

20.

Koepke, J P, Angelo J. Trapani, Philippe R. Bovy, et al.. (1989). Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.. Journal of Pharmacology and Experimental Therapeutics. 249(1). 172–176. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact